Latest California Healthline Stories
CalPERS Taps UnitedHealth To Run Its Prescription Drug Business
Controlling costs was a big consideration in awarding the nearly $4.9 billion contract to OptumRx, a unit of the insurance giant.
Three Firms Vie To Run CalPERS’ Drug Benefits
UnitedHealth’s OptumRx is the lowest bidder and wins a key endorsement ahead of final vote by California’s public retirement system.
Five Health Issues Presidential Candidates Aren’t Talking About — But Should Be
The U.S. faces a variety of serious concerns beyond just the future of the federal health law.
Will Rx Ballot Initiative Save Money? Report Offers An Educated Shrug
A ballot measure in November would peg state-paid drug prices to the lowest prices paid by the U.S. Department of Veterans Affairs. But there’s a catch: The VA won’t say what those prices are.
In June, California will become the fifth state to allow terminally ill patients to end their lives with prescriptions from their doctors, but getting those prescriptions will require serious effort.
More Exchange Plans Offer Patients Easier Access To Some Expensive Drugs: Report
The analysis by Avalere examines changes in how silver plans on the insurance marketplaces handle coverage for high-cost specialty drugs.
What’s California’s Prescription For Rising Drug Costs?
How high-cost drugs are impacting California.
Key Senate Committee Votes For More Transparency On Drug Price Hikes
Proposed legislation would require drugmakers to give 60-day notice for price increases of 10 percent or more and provide written justification for them.
Mortgages For Expensive Health Care? Some Experts Think It Can Work.
An MIT economist and Harvard oncologist propose offering loans to patients to cover the cost of expensive, curative drugs, financed by private sector investment in loan securities.
Pharmaceutical Company Has Hiked Price On Aid-In-Dying Drug
Valeant Pharmaceuticals, the company that makes Seconal, the drug most commonly used in prescribed for terminally ill patients who want to end their lives, physician-assisted suicide, has doubled the price to more than $3,000.